FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/103734 [Registered on: 12/02/2026] Trial Registered Prospectively
Last Modified On: 10/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Effect of melatonin before surgery helps to reduce anxiety and keep vitals stable 
Scientific Title of Study   Effect of preoperative oral melatonin on perioperative anxiety and hemodynamic response to intubation: A double-blind randomized controlled trial in patients undergoing surgery under general anesthesia 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Supriya 
Designation  Postgraduate student  
Affiliation  Bangalore medical college and research institute  
Address  Major OT Complex,room no.48,Anaesthesia department, 3rd floor, MPB Building, Victoria hospital, Fort Krishna Rajendra Road, Bengaluru
Major OT complex,room no. 48,Anaesthesia department,3rd floor,MPB building Victoria hospital,Fort Krishna Rajendra road,Bengaluru
Bangalore
KARNATAKA
560002
India 
Phone  9480588135  
Fax    
Email  Supriyasiri1996@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Madhu KP 
Designation  Assistant Professor  
Affiliation  Bangalore medical college and research institute  
Address  Major OT Complex,room no.48,Anaesthesia department,3rd floor, MPB Building, Victoria hospital, Fort Krishna Rajendra Road, Bengaluru
Major OT Complex,room no.48,Anaesthesia department,3rd floor,MPB Building,Victoria Hospital,Fort Krishna Rajendra road ,Bengaluru
Bangalore
KARNATAKA
560002
India 
Phone  9380455534  
Fax    
Email  drmadhukp@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Swathi N 
Designation  Assistant Professor  
Affiliation  Bangalore medical college and research institute  
Address  Major OT Complex,room no.48,Anaesthesia department, 3rd floor, MPB Building, Victoria hospital, Fort Krishna Rajendra Road, Bengaluru
Mor OT Complex,room no.48,Anaesthesia department,3rd floor,MPB Building,Victoria Hospital,Fort Krishna Rajendra road,Bengaluru
Bangalore
KARNATAKA
560056
India 
Phone  9972454989  
Fax    
Email  swathisaggi@gmail.com  
 
Source of Monetary or Material Support  
Bangalore Medical College and Research Institute 
 
Primary Sponsor  
Name  Supriya 
Address  Bangalore medical college and research institute Fort Krishna Rajendra Rd Bengaluru-560002 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Swathi N  Bangalore medical college and research institute   Major OT complex, 3rd floor, Depart of Anaesthesia, MPB Building, Victoria hospital, Bangalore-560002
Bangalore
KARNATAKA 
09972454989

swathisaggi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Bangalore Medical College and Research Ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Tablet Melatonin 6 mg   Tablet given 60 minutes before general anaesthesia induction 
Comparator Agent  Tablet Multivitamin  Tablet given 60 minutes before general anaesthesia induction 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients who are willing to give written consent
ASA 1/2 patients who will undergo surgical procedures under general anaesthesia
No use of anxiolytic narcotic 24 hours before surgery
Non pregnant females  
 
ExclusionCriteria 
Details  Patient with reduced level of consciousness
Known history of allergy to drugs
Advanced hepatic renal and respiratory diseases
Patients with anticipated difficult Airway
Patients with uncontrolled hypertension and diabetes mellitus 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Hamilton anxiety score  Pre-operative and post-operative at 2 hours and 6 hours post-op  
 
Secondary Outcome  
Outcome  TimePoints 
Hemodymanics, VAS score, Ramsay sedation score, side effects  Preoperative, intra-operative & post-operatively at 2 hours & 6 hours 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   21/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [swathisaggi@gmail.com].

  6. For how long will this data be available start date provided 23-07-2025 and end date provided 24-09-2029?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Laryngoscopy and endotracheal intubation are potent noxious stimuli that can elicit significant sympathetic responses, resulting in undesirable cardiovascular, respiratory, and physiological alterations. These perioperative stress responses are further compounded by preoperative anxiety, which is known to adversely affect patient outcomes. The selection of appropriate premedication and anesthetic strategies plays a critical role in mitigating these effects.


Melatonin, a naturally occurring hormone, has demonstrated anxiolytic, sedative, and analgesic properties, with the added advantage of minimal impact on hemodynamic stability. Given its favorable pharmacological profile, melatonin may serve as an effective premedicant for attenuating anxiety and blunting the hemodynamic response to laryngoscopy and intubation.


Therefore, this study aims to evaluate the efficacy of preoperative oral melatonin in reducing perioperative anxiety and suppressing hemodynamic responses during laryngoscopy and intubation in patients undergoing surgery under general anesthesia.


 
Close